SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-026122
Filing Date
2019-07-25
Accepted
2019-07-25 16:16:15
Documents
46
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20190630.htm 10-Q 1092212
2 EX-31.1 mnov-ex311_9.htm EX-31.1 11000
3 EX-31.2 mnov-ex312_7.htm EX-31.2 10902
4 EX-32.1 mnov-ex321_6.htm EX-32.1 7878
5 EX-32.2 mnov-ex322_8.htm EX-32.2 7804
  Complete submission text file 0001564590-19-026122.txt   3378232

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20190630.xml EX-101.INS 545892
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20190630.xsd EX-101.SCH 27830
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20190630_cal.xml EX-101.CAL 31971
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20190630_def.xml EX-101.DEF 83466
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20190630_lab.xml EX-101.LAB 246179
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20190630_pre.xml EX-101.PRE 183808
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 19974634
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences